Pacific Biosciences of California, Inc. (FRA:P09)

FRA:P09 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	413	481	520	2,374	1,731	3,969
Market Cap Growth	-10.95%	-7.57%	-78.08%	37.15%	-56.39%	0.45%
Enterprise Value	772	825	955	2,526	1,837	3,857
Last Close Price	1.40	1.52	1.77	8.86	7.74	17.16
PS Ratio	3.03	3.53	3.50	13.08	14.42	34.58
PB Ratio	90.56	105.55	1.06	3.74	3.29	5.71
EV/Sales Ratio	5.68	6.06	6.42	13.93	15.30	33.61
Debt / Equity Ratio	131.32	131.32	1.33	1.33	1.69	1.21
Net Debt / Equity Ratio	79.06	79.06	0.56	0.43	0.31	-0.11
Net Debt / EBITDA Ratio	-8.03	-8.03	-1.13	-1.04	-0.60	0.52
Net Debt / FCF Ratio	-	-	-1.33	-1.13	-0.63	0.76
Asset Turnover	0.16	0.16	0.10	0.11	0.07	0.11
Inventory Turnover	1.95	1.95	1.84	2.66	2.00	3.68
Quick Ratio	5.79	5.79	6.30	7.03	3.00	14.90
Current Ratio	6.92	6.92	7.48	7.81	3.24	15.36
Return on Equity (ROE)	-213.45%	-213.45%	-51.30%	-48.53%	-46.42%	-32.17%
Return on Assets (ROA)	-34.09%	-34.09%	-12.08%	-11.04%	-10.10%	-9.20%
Return on Capital Employed (ROCE)	-76.40%	-76.40%	-24.30%	-18.80%	-20.30%	-9.20%
Earnings Yield	-112.79%	-96.78%	-57.53%	-11.69%	-16.99%	-4.01%
FCF Yield	-	-	-39.41%	-10.21%	-15.14%	-2.60%
Buyback Yield / Dilution	-9.28%	-9.28%	-8.22%	-12.95%	-10.00%	-16.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.